UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population

Journal of vascular surgery, 2014-09, Vol.60 (3), p.686-695.e2

2014

Volltextzugriff (PDF)

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

The New England journal of medicine, 2017-01, Vol.376 (1), p.32-40

2017

Volltextzugriff (PDF)

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2459-2502

2016

Volltextzugriff (PDF)

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Thrombosis and haemostasis, 2020-05, Vol.120 (5), p.866-875

2020

Volltextzugriff (PDF)

Reducing LDL with PCSK9 Inhibitors — The Clinical Benefit of Lipid Drugs

The New England journal of medicine, 2015-10, Vol.373 (17), p.1588-1591

2015

Volltextzugriff (PDF)

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

Vascular medicine (London, England), 2020-04, Vol.25 (2), p.103-105

Hiatt, William R

2020

Volltextzugriff (PDF)

Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2019-01, Vol.139 (4), p.e10-e33

2019

Volltextzugriff (PDF)

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee

Catheterization and cardiovascular interventions, 2015-10, Vol.86 (4), p.611-625

2015

Volltextzugriff (PDF)

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

Circulation (New York, N.Y.), 2017-01, Vol.135 (3), p.241-250

2017

Volltextzugriff (PDF)

Pathogenesis of the Limb Manifestations and Exercise Limitations in Peripheral Artery Disease

Circulation research, 2015-04, Vol.116 (9), p.1527-1539

2015

Volltextzugriff (PDF)

Alan Hirsch, MD: 1954-2017

Circulation research, 2017-05, Vol.120 (11), p.1702-1703

Hiatt, William R

2017

Volltextzugriff (PDF)

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

Diabetologia, 2019-06, Vol.62 (6), p.926-938

2019

Volltextzugriff (PDF)

Inflammatory Cytokines Associated With Failure of Lower Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes

Diabetes care, 2019-10, Vol.42 (10), p.1939-1945

2019

Volltextzugriff (PDF)

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Circulation (New York, N.Y.), 2017-06, Vol.135 (25), p.2534-2555

2017

Volltextzugriff (PDF)

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials

JAMA : the journal of the American Medical Association, 2009-05, Vol.301 (18), p.1909

2009

Volltextzugriff (PDF)

Acute Limb Ischemia in Peripheral Artery Disease: Insights From EUCLID

Circulation (New York, N.Y.), 2019-08, Vol.140 (7), p.556-565

2019

Volltextzugriff (PDF)

Rivaroxaban in Peripheral Artery Disease after Revascularization. Reply

The New England journal of medicine, 2020-11, Vol.383 (21), p.2090-2091

2020

Volltextzugriff (PDF)

Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)

Journal of the American College of Cardiology, 2015-03, Vol.65 (9), p.931-941

2015

Volltextzugriff (PDF)

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

Circulation (New York, N.Y.), 2020-12, Vol.142 (23), p.2219-2230

2020

Volltextzugriff (PDF)

Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back

European heart journal, 2020-05, Vol.41 (17), p.1650-1652

2020

Volltextzugriff (PDF)

Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery Revascularization

Journal of the American College of Cardiology, 2020-02, Vol.75 (5), p.498-508

2020

Volltextzugriff (PDF)

Obituary – John A Dormandy (5.3.1937–26.4.2019)

European journal of vascular and endovascular surgery, 2019-09, Vol.58 (3), p.466-466

2019

Volltextzugriff (PDF)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Journal of endovascular therapy, 2015-10, Vol.22 (5), p.663-677

2015

Volltextzugriff (PDF)

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications

Thrombosis and haemostasis, 2016-06, Vol.115 (6), p.1240-1248

2016

Volltextzugriff (PDF)

The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease

Circulation (New York, N.Y.), 2014-07, Vol.130 (1), p.69-78

2014

Volltextzugriff (PDF)

1 – 25 von 535

Suche als RSS-Feed

Aktive Filter

ThemaBlood And Lymphatic Vessels

ThemaCardiovascular Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(464)
Mit Volltextzugriff
(423)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(534)

Erscheinungsjahr

n.n

Thema

Science & Technology
(316)
Life Sciences & Biomedicine
(310)
Humans
(277)
Male
(148)
Female
(146)
Cardiovascular System & Cardiology
(139)
Biological And Medical Sciences
(100)
Middle Aged
(100)
Peripheral Vascular Disease
(91)
Aged
(85)
Cardiac & Cardiovascular Systems
(81)
Medical Sciences
(81)
Risk Factors
(64)
Adult
(62)
Treatment Outcome
(54)
Peripheral Artery Disease
(48)
Surgery
(46)
General & Internal Medicine
(34)
Medicine, General & Internal
(33)
United States
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Reducing LDL with PCSK9 Inhibitors — The Clinical Benefit of Lipid Drugs

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

Pathogenesis of the Limb Manifestations and Exercise Limitations in Peripheral Artery Disease

Alan Hirsch, MD: 1954-2017

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

Inflammatory Cytokines Associated With Failure of Lower Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials

Acute Limb Ischemia in Peripheral Artery Disease: Insights From EUCLID

Rivaroxaban in Peripheral Artery Disease after Revascularization. Reply

Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety

Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back

Long-Term Outcomes and Associations With Major Adverse Limb Events After Peripheral Artery Revascularization

Obituary – John A Dormandy (5.3.1937–26.4.2019)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications

The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease

Aktive Filter

Suchergebnisse filtern